Onconova Therapeutics Inc.

(ONTX) Trade

By |

Profile

Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab.

Contact Information

Website: www.onconova.com
Email: ir@onconova.us
Main Phone: +1 267 759-3680
Address: 375 Pheasant Run
State: PA
City / Town: Newtown
Country: US
Postal Code: 18940

Issuer Information

Exchange: NSC
CEO: Steven M. Fruchtman
Employees: 19
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab.

Contact Information

Website: www.onconova.com
Email: ir@onconova.us
Main Phone: +1 267 759-3680
Address: 375 Pheasant Run
State: PA
City / Town: Newtown
Country: US
Postal Code: 18940

Issuer Information

Exchange: NSC
CEO: Steven M. Fruchtman
Employees: 19
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 1.18 $ -0.1119 (-8.67%)
Last Price 1.18 Change $ -0.1119 Change % -8.67 Tick N/A
Bid 1.17 Bid Size 39,000.00 Ask 1.18 Ask Size 25,400.00
Open 1.33 High 1.33 Low 1.17 Prev Close 1.29
Last Trade Volume 19.9 mi 52 Wk Hi 1.93 52 Wk Low 0.20
Market Cap 278.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 236,612,391.00 EPS (TTM) 1.04 PE Ratio 1.20 Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 6
Number of Buys 5 6
Number of Sells 0 0
Net Activity 2610115 2660115
Last 10 Buys Shares
Henry S. Bienen 1,000
E. Premkumar Reddy 1,000
Michael B. Hoffman 1,000
Jack E. Stover 1,000
James J. Marino 1,000
James J. Marino 1,000
Henry S. Bienen 1,000
Mark Guerin 1,000
E. Premkumar Reddy 1,000
Ramesh Kumar 1,000
Last 10 Sell Shares
Ramesh Kumar 1,000
Ramesh Kumar 1,000
Ramesh Kumar 1,000
Ramesh Kumar 1,000
Ramesh Kumar 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3.67 3.67 3.67 3.67
Standard Deviation 1.15 1.15 1.15 1.15
Date of Most Recent Estimate 05/15/18 05/15/18 05/15/18 05/15/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 2 2
Moderate Buy 0 0 0 0
Hold 0 0 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1.67 1.67